Long-term Complications Associated with Glaucoma Drainage Devices and Boston Keratoprosthesis
Overview
Affiliations
Purpose: To evaluate long-term complications related to glaucoma drainage devices in patients undergoing Boston type 1 keratoprosthesis surgery.
Design: Retrospective case series.
Methods: All patients who underwent Boston type 1 keratoprosthesis surgery at the University of California, Davis, between 2004 and 2010 were included. Preoperative and postoperative data were reviewed. Twenty-five eyes with glaucoma drainage devices were highlighted. Visual acuity and postoperative complications were tracked at postoperative months 1, 3, 6, 9, and 12 and at annual intervals thereafter.
Results: Forty eyes of 35 patients were evaluated with an average follow-up of 33.6 months. Conjunctival breakdown occurred in association with 10 glaucoma drainage device implants in 9 eyes. Eleven eyes had glaucoma drainage devices placed before keratoprosthesis surgery, 3 eyes underwent glaucoma drainage device placement at the time of surgery, and 2 eyes had a glaucoma drainage device placed after surgery. All but one of the eroded glaucoma drainage devices were placed before surgery. Associated complications included endophthalmitis, hypotony, and keratoprosthesis extrusion, with 6 glaucoma drainage devices requiring removal. Long-term beset-corrected visual acuity was maintained better in eyes in which glaucoma drainage device erosions did not develop.
Conclusions: One of the main challenges with keratoprosthesis surgery is treating concurrent glaucoma. Glaucoma drainage devices have been advocated as a way to address this long-term complication, but this series suggests that glaucoma drainage device-related complications can cause significant vision loss.
Orive Banuelos A, Arana Larrea B, Crnej A, Arce Soto A, Andollo Victoriano N, Ecenarro J Case Rep Ophthalmol. 2022; 13(1):158-165.
PMID: 35611024 PMC: 9082173. DOI: 10.1159/000522440.
Challenges of Glaucoma Management in Patients with Type I Boston Keratoprosthesis.
AlHilali S, Al-Swailem S Clin Ophthalmol. 2022; 16:369-374.
PMID: 35177895 PMC: 8846611. DOI: 10.2147/OPTH.S349719.
Islam Y, Blake C, Gibran S Eye (Lond). 2021; 35(7):1850-1858.
PMID: 33674726 PMC: 8225646. DOI: 10.1038/s41433-021-01462-9.
Boston Type 1 Keratoprosthesis: Updated Perspectives.
Nonpassopon M, Niparugs M, Cortina M Clin Ophthalmol. 2020; 14:1189-1200.
PMID: 32425503 PMC: 7196770. DOI: 10.2147/OPTH.S219270.
Oh D, Michael R, Vajaranant T, Cortina M, Shorter E Ther Adv Ophthalmol. 2019; 11:2515841419868559.
PMID: 31448361 PMC: 6691656. DOI: 10.1177/2515841419868559.